Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis. (Q42236619)

19 October 2017

title

Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis. (English)

1 reference

19 October 2017

3

Carsten Tschöpe

1 reference

19 October 2017

Ronny Malz

1

1 reference

19 October 2017

Alice Weithauser

series ordinal

2

1 reference

19 October 2017

Heinz-Peter Schultheiss

series ordinal

4

1 reference

19 October 2017

Ursula Rauch

series ordinal

5

1 reference

19 October 2017

publication date

1 June 2014

1 reference

Cardiovascular Therapeutics

19 October 2017

published in

1 reference

19 October 2017

volume

32

1 reference

19 October 2017

issue

3

1 reference

19 October 2017

page(s)

113-119

1 reference

Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity.

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Protease activated receptors in cardiovascular function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Bivalirudin inhibits periprocedural platelet function and tissue factor expression of human smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Circulating tissue factor and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Factor Xa: at the crossroads between coagulation and signaling in physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Matricellular Proteins: New Molecular Targets To Prevent Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

The quest for new anticoagulants: from clinical development to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Matrix metalloproteinases in the pathogenesis of viral heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Protective and pathogenic functions of macrophage subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12069

21 January 2018

Identifiers

DOI

10.1111/1755-5922.12069

1 reference

19 October 2017

1 reference